Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Morgan Stanley recently adjusted its investment rating for Novo Nordisk, upgrading it from "underweight" to "hold."

Morgan Stanley recently adjusted its investment rating for Novo Nordisk, upgrading it from "underweight" to "hold."

老虎证券老虎证券2026/03/03 07:59
Show original
Meanwhile, the investment bank has lowered the target price for Novo Nordisk from $42 to $40. This rating adjustment reflects Morgan Stanley's reassessment of Novo Nordisk's future performance.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!